Moore KN, Birrer MJ, Marsters J, Wang Y, et al. Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer. Gynecol Oncol 2020 Jun 11. pii: S0090-8258(20)31124.
PMID: 32534811